Helen Marshall1, Laurie J Smith1, Alberto M Biancardi1, Guilhem J Collier1, Andreas Voskrebenzev2, Jens Vogel-Claussen2, and Jim M Wild1
1POLARIS, Academic Radiology, University of Sheffield, Sheffield, United Kingdom, 2Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany
Synopsis
Free-breathing
1H MRI offers a means of producing surrogate ventilation images without
use of a contrast agent but more validation against direct ventilation imaging
methods such as hyperpolarised gas MRI is required. 24 patients with cystic fibrosis were scanned
with 1H and 129Xe ventilation MRI. There were strong correlations between 1H
ventilation defect percentage (VDP), 129Xe VDP, lung clearance index
and FEV1. 1H VDP
was typically smaller than 129Xe VDP with wide limits of agreement
(LOA) (bias 2.8%, LOA -13.7%, 19.3%). Both similarities and differences between
129Xe and 1H ventilation images were observed across the
range of disease severity.
Introduction
Free-breathing 1H MRI can produce surrogate maps
of ventilation without the use of a contrast agent. 1H ventilation metrics correlate
strongly with lung clearance index (LCI)1
and show good short-term reproducibility2
in children with cystic fibrosis (CF). However,
little validation has been performed against methods which directly image lung
ventilation in patients. Hyperpolarised
gas MRI using 129Xe or 3He provides ventilation images
with signal directly proportional to the density of the inhaled tracer gas.
Single slice measurements of 1H ventilation
defect percentage (VDP) have shown moderate correlation with whole lung 129Xe
VDP in children with CF3, and strong correlation with
matched-slice 3He VDP in patients with CF4. However, a large bias between 3He
and 1H VDP values and varying degrees of visual agreement between 3He
and 1H ventilation images have been observed4.
The aim of this work was to investigate the
relationship between 1H and 129Xe ventilation images
across the whole lung in patients with a broad spectrum of CF lung disease.Methods
24 patients (aged 9 to 47) were scanned using a 1.5T whole
body MRI system (GE HDx). Sequence
parameters are shown in table 1.
Patients also underwent spirometry and LCI testing.
129Xe MRI:
Patients were positioned supine in a 129Xe transmit-receive
coil (CMRS). A mix (0.65-1L) of
hyperpolarised 129Xe (~25% polarisation, 86% 129Xe, 0.4-0.5L)
and N2 was inhaled from functional residual capacity (FRC), with gas
volumes determined by patient height, and 129Xe ventilation images
were acquired during breath-hold. 1H
anatomical images of the same imaging volume were also acquired.
Free-breathing 1H MRI: Patients were positioned supine in an
8-element chest array (GE) and 250 dynamic images per slice were acquired
during relaxed free-breathing. Phase-resolved
functional lung (PREFUL) analysis5 was performed, including registration, low-pass
filtering and calculation of fractional ventilation.
Analysis: Ventilation defect percentage (VDP) was
calculated from the 129Xe and PREFUL ventilation images in the same
manner. The anatomical 1H
image volumes associated with the ventilation images were segmented
semi-automatically using spatial fuzzy C-means thresholding6 to produce lung cavity masks with the large
airways and vessels excluded. Linear
binning7 of the ventilation images was performed with
histograms scaled by the mean signal inside the lung cavity mask8, and the resulting ventilation defect region (1st
bin) was used to calculate VDP.
Correlations between metrics were performed, and Bland-Altman analysis
was used to assess agreement between 129Xe and 1H VDP.Results and Discussion
Patient
demographics, pulmonary function test results and VDP values are summarised in
table 2.
There
was a strong correlation between 129Xe VDP and 1H VDP
(r=0.89, p<0.01, figure 1a). Mean 1H
VDP was lower than mean 129Xe VDP with a bias of 2.8% (figure 1b)
and limits of agreement at -13.7% and 19.3%.
The correlations of 129Xe VDP with LCI (r=0.91) and FEV1
z-score (r=-0.83) were stronger than those of 1H VDP with LCI
(r=0.82) and FEV1 z-score (r=-0.78), all p<0.01. Linear binning allowed user-independent
evaluation of VDP with both techniques treated equally.
Similarities (e.g. figure 2) and differences (e.g. figure 3) were
observed between 129Xe and 1H ventilation images across
the range of disease severity. Regions
of reduced 1H ventilation were often associated with 129Xe
ventilation defects or heterogeneity but did not always capture their full
extent or detailed patterns evident on 129Xe images (e.g. figure
2). In some cases, the appearance of 129Xe
and 1H ventilation images were dissimilar (e.g. figure 3), which was
possible even when 129Xe and 1H VDP values were
concordant (e.g. figure 3a-d). Of
particular relevance in patients with normal FEV1, small defects and
patchy ventilation heterogeneity visible with 129Xe MRI were not
seen on 1H ventilation images (e.g. figure 3a,b). Images from the patient with the largest
difference between 129Xe and 1H VDP are shown in figure
3e,f.
Differences between techniques may be due to the
fundamentally different sources of image contrast; inhaled 129Xe gas
density and 1H signal modulation due to respiratory motion. Study limitations include differing voxel
size, lung coverage, lung volumes during image acquisition and some error in
matching of image planes for visual comparison.
In particular, the lower spatial resolution of the 1H ventilation
images (3.75x3.75x15mm) compared to the 129Xe images
(3.5x3.5x10mm - 4.5x4.5x10mm) may in part explain the bias towards lower 1H
VDP.Conclusions
Ventilation
defect percentage calculated from 1H free-breathing MRI showed
strong correlations with 129Xe VDP, LCI and FEV1 z-score. 1H VDP was lower than 129Xe
VDP with a bias of 2.8% and limits of agreement at -13.7% and 19.3%. Both similarities and differences between 129Xe
and 1H ventilation images were observed across the range of disease
severity. Reduced 1H
ventilation was often, but not always, associated with 129Xe
ventilation defects or heterogeneity. Small
defects and patchy ventilation heterogeneity observed in early-stage CF lung
disease on 129Xe ventilation images were not visualised with 1H
ventilation MRI. The cause of the
uncertainty in agreement between the techniques is unknown and warrants further
investigation.Acknowledgements
National Institute for Health Research and Medical Research
Council for funding.References
1. Nyilas S, Bauman
G, Sommer G, et al. Novel magnetic resonance technique for functional imaging of
cystic fibrosis lung disease. Eur Respir J 2017;50.
2. Nyilas S, Bauman
G, Pusterla O, et al. Ventilation and perfusion assessed by functional MRI in
children with CF: reproducibility in comparison to lung function. J Cyst Fibros
2019;18:543-50.
3. Couch MJ, Rayment
JH, Grimm R, et al. Comparison of Phase-Resolved Functional Lung (PREFUL) MRI
and Hyperpolarized 129Xe MRI in Pediatric Cystic Fibrosis. International Society for Magnetic Resonance
in Medicine; 2019; Montreal, Canada. p. 0006.
4. Marshall H,
Voskrebenzev A, Biancardi A, et al. Investigating the relationship between
free-breathing 1H and breath-hold 3He MRI in patients with cystic
fibrosis. International Society for
Magnetic Resonance in Medicine; 2019; Montreal, Canada. p. 0014.
5. Voskrebenzev A,
Gutberlet M, Klimes F, et al. Feasibility of quantitative regional ventilation
and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in
healthy volunteers and COPD, CTEPH, and CF patients. Magn Reson Med
2018;79:2306-14.
6. Hughes PJC, Horn
FC, Collier GJ, Biancardi A, Marshall H, Wild JM. Spatial fuzzy c-means
thresholding for semiautomated calculation of percentage lung ventilated volume
from hyperpolarized gas and (1) H MRI. J Magn Reson Imaging 2018;47:640-6.
7. He M, Driehuys B,
Que LG, Huang YT. Using Hyperpolarized (129)Xe MRI to Quantify the Pulmonary
Ventilation Distribution. Acad Radiol 2016;23:1521-31.
8. Collier
GJ, Acunzo L, Smith LJ, et al. Linear binning maps for image analysis of
pulmonary ventilation with hyperpolarized gas MRI: transferability and clinical
applications. International Society for
Magnetic Resonance in Medicine; 2018; Paris. p. 4482.